ASAlice Schuch

Alice Schuch

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alice Schuch has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • MRI risk stratification in metabolic dysfunction–associated steatotic liver disease (MASLD): from diffuse liver disease to focal lesions

    by Gabriela Carboni, Natália Henz Concatto, Rubia Vanceta, Henrique Meira Guerra, Alice Schuch

    Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide. Hepatic steatosis, its imaging hallmark, is a frequent incidental finding in abdominal imaging, often prompting further clinical evaluation. Despite this, the integration of imaging-derived biomarkers into structured risk stratification pathways and longitudinal disease management remains inconsistent in clinical practice. This narrative review outlines the role of multiparametric magnetic resonance imaging (MRI) in the assessment of MASLD, focusing on clinically actionable applications for abdominal radiology. Quantitative MRI biomarkers - including proton density fat fraction (MRI-PDFF), magnetic resonance elastography (MRE), R2* iron quantification, and gadoxetic acid-enhanced MRI - provide complementary information for evaluation of steatosis, fibrosis, iron overload, hepatocellular function, and focal liver lesions. The contribution of multiparametric MRI to opportunistic disease detection, identification of clinically significant fibrosis, and longitudinal monitoring of disease progression and therapeutic response is summarized. Key imaging pitfalls in steatotic livers are addressed, including altered lesion conspicuity, heterogeneous fat and stiffness distribution, focal stiffness abnormalities, and diagnostic challenges related to hepatocellular carcinoma in non-cirrhotic MASLD. Multiparametric MRI enables comprehensive, noninvasive, whole-liver evaluation of MASLD and supports imaging-informed risk stratification and longitudinal disease management in abdominal radiology practice.

  • Imaging of intrauterine contraceptive devices: a comprehensive pictorial review

    by Camila Braga Visconti, Gabriela Carboni, Ariane Giovanaz, Patrícia Valesca Leal, Rubia Vanceta, Alice Schuch, Natália Henz Concatto

    Intrauterine contraceptive devices (IUCDs) are widely used, highly effective, and reversible methods of contraception. Despite their overall safety profile, IUCD malposition and complications May occur and are frequently asymptomatic or clinically unsuspected, posing a diagnostic challenge in daily practice. Imaging plays a central role in evaluating IUCD location, integrity, and associated complications, often in patients undergoing ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) for unrelated indications. Familiarity with the different types of IUCDs and their expected imaging appearances is essential for accurate interpretation. Proper positioning requires complete intrauterine placement with fundal orientation, while deviations May represent a spectrum of malposition, including expulsion, displacement, embedment, and uterine perforation. Additional complications such as fragmentation, missing retrieval strings, pelvic inflammatory disease, actinomycosis, and pregnancy with an IUCD in situ further broaden the differential diagnosis. Recognition of key imaging features and common diagnostic pitfalls is critical, as some findings warrant prompt clinical communication and intervention. Integrating this knowledge into routine imaging assessment enhances diagnostic accuracy, supports appropriate clinical management, and reduces the risk of overlooked IUCD-related complications

  • Open Access

    Avaliação sequencial da fibrose hepática na era da nomenclatura MASLD

    by Alice Schuch, Gabriela Carboni, Louise Torres, Mario Reis Álvares-Da-Silva

  • Advances in prostate cancer imaging: from detection to post-treatment

    by Marília da Cruz Fagundes, Fernando Morbeck Almeida Coelho, Guilherme Gotti Naves, Giovanna Sawaya Torre, Marcelo de Macêdo Gusmão, Alice Schuch, Thaís Caldara Mussi, Mauricio Zapparoli, Ronaldo Hueb Baroni

    Advancements in prostate imaging, particularly multiparametric magnetic resonance imaging (mpMRI), have transformed the diagnosis and monitoring paradigms for prostate cancer (PCa). However, considerable interobserver variability has been reported,emphasizing the importance of standardized scoring and reporting systems. The Prostate Imaging Reporting and Data System (PI-RADS), along with quality assurance protocols such as Prostate Imaging Quality (PI-QUAL), has enhanced the diagnostic accuracy of mpMRI. While mpMRI effectively identifies extraprostatic extension, emerging hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) and radio labeled prostate-specific membrane antigen (PSMA) tracers have improved metastasis detection. In active surveillance settings, the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation (PRECISE) recommendations enable the assessment of longitudinal PCa changes. Post-treatment evaluation can also employ dedicated frameworks, such as the Prostate Imaging for Recurrence Reporting (PI-RR) after radical prostatectomy, and either the Prostate Imaging after Focal Ablation (PI-FAB) or the Transatlantic Recommendations for Prostate Gland Evaluation with MRI after Focal Therapy (TARGET). This article reviews key aspects of mpMRI, including structured interpretation frameworks beyond the widely recognized PI-RADS.


  • Open Access

    Patologias não neoplásicas e neoplásicas da bolsa testicular na ressonância magnética: um ensaio iconográfico

    by Thiago de Oliveira Caetano, Alice Schuch, Ivan Morzoletto Pedrollo

    Resumo A ressonância magnética é uma ferramenta importante na avaliação da bolsa testicular em casos com achados inconclusivos pela ultrassonografia. A capacidade da ressonância magnética de diferenciar entre lesões intratesticulares e extratesticulares, bem como entre condições neoplásicas e não neoplásicas, tem papel crucial na caracterização de lesões, no estadiamento de tumores e auxilia na decisão pré-operatória. Este ensaio apresenta imagens de ressonância magnética que destacam as principais patologias não neoplásicas e neoplásicas. O reconhecimento dessas patologias reforça o papel do médico radiologista na linha de cuidado de pacientes com lesões da bolsa testicular mediante uma avaliação adequada das suas características de imagem.

  • Open Access

    Non-neoplastic and neoplastic scrotal pathologies on magnetic resonance imaging: a pictorial essay

    by Thiago de Oliveira Caetano, Alice Schuch, Ivan Morzoletto Pedrollo

    Magnetic resonance imaging is an essential tool for the assessment of the scrotum, particularly in cases with inconclusive ultrasound findings. It has a great capacity to differentiate between intratesticular and extratesticular lesions, as well as between neoplastic and non-neoplastic lesions. By providing an accurate characterization of lesions, magnetic resonance imaging plays a crucial role in preoperative tumor staging and decision-making. This pictorial essay highlights the key non-neoplastic and neoplastic testicular pathologies, as evaluated by magnetic resonance imaging. The recognition of these pathologies underscores the role the radiologists play in the care of patients with scrotal lesions, by providing an appropriate evaluation of the relevant imaging characteristics.

  • Open Access

    Metástases para linfonodos inguinais no câncer de próstata: um novo olhar sobre um padrão incomum de disseminação

    by Alice Schuch

    O câncer de próstata é a segunda neoplasia mais comum em homens, atrás apenas do câncer de pele não melanoma(1 1 Gandaglia G, Abdollah F, Schiffmann J, et al. Distribution of metastatic sites in patients with prostate cancer: a population-based analysis. Prostate. 2014;74:210–6. ). A disseminação metastática do câncer de próstata ocorre por invasão local, disseminação linfática e hematogênica, sendo os linfonodos pélvicos e os ossos os sítios mais comuns, encontrados em 99% e 84% dos casos, respectivamente(2 2 Swanson GP, Hubbard JK. A better understanding of lymphatic drainage of the prostate with modern imaging and surgical techniques. Clin Genitourin Cancer. 2013;11:431–40. ). A dúvida referente ao comprometimento de linfonodos inguinais surgiu principalmente com a maior utilização de métodos de imagens seccionais como a TC e a RM, e também pela avaliação metabólica por PET, especialmente com radiofármacos específicos para câncer de próstata, como o PSMA. As metástases para linfonodos inguinais são consideradas raras e representam um desafio diagnóstico por não serem incluídas nos campos de tratamento convencionais de radioterapia ou linfadenectomia. A real prevalência e os fatores preditivos para linfonodos inguinais metastáticos permanecem incertos, com a literatura existente baseada em achados de imagem, sem correlação histopatológica(3 3 Jackson ASN, Sohaib SA, Staffurth JN, et al. Distribution of lymph nodes in men with prostatic adenocarcinoma and lymphadenopathy at presentation: a retrospective radiological review and implications for prostate and pelvis radiotherapy. Clin Oncol (R Coll Radiol). 2006;18:109–16. ,4 4 Schiller K, Stöhrer L, Düsberg M, et al. PSMA-PET/CT-based lymph node atlas for prostate cancer patients recurring after primary treatment: clinical implications for salvage radiation therapy. Eur Urol Oncol. 2021;4:73–83. ).